Use of Lambda-Mu-Sigma-Derived Z score for evaluating respiratory impairment in Middle-Aged persons

Respiratory Care

Volumn 56, Issue 11, 2011, Pages 1771-1777

  Vaz Fragoso, Carlos A ^a,b   Gill, Thomas M ^b   Mcavay, Gail ^b   van Ness, Peter H ^b   Klar Yaggi, H ^a,b   Concato, John ^a,b  

^a VA CONNECTICUT HEALTHCARE SYSTEM   (United States)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Airflow limitation; Mortality; Respiratory symptoms; Restrictive pattern; Spirometry

Indexed keywords

ADULT; AIRWAY OBSTRUCTION; ARTICLE; BREATHING PATTERN; DISEASE ASSOCIATION; FEMALE; HAZARD RATIO; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; RESPIRATORY AIRFLOW; RESPIRATORY TRACT DISEASE; SCORING SYSTEM; SPIROMETRY;

FEMALE; HUMANS; MALE; MIDDLE AGED; NUTRITION SURVEYS; REFERENCE VALUES; RESPIRATORY TRACT DISEASES; SPIROMETRY;

EID: 82455167132     PISSN: 00201324     EISSN: 19433654     Source Type: Journal    
DOI: 10.4187/respcare.01192     Document Type: Article

References (33)

1. Thorne SL, Malarcher A, Maurice E, Caraballo R. Cigarette smoking among adults: United States, 2007. MMWR 2008;57(45):1221-1226.
2. Schindler C, Kunzli N, Bongard JP, Leuenberger P, Karrer W, Rapp R, et al. Short-term variation in air pollution and in average lung function among never-smoker: the Swiss study on air pollution and lung diseases in adults (SALPADIA). Am J Respir Crit Care Med 2001;163(2):356-361.
3. Raherison C, Girodet P-O. Epidemiology of COPD. Eur Respir Rev 2009;18(114):213-221.
4. Murray CJL, Lopez AD. Evidence-based health policy. Lessons from the global burden of disease study. Science 1996;274(5288):740-743.
5. Rabe1 KF, Hurd S, Anzueto A, Barnes PJ, Buist SA, Calverley P, et al. The global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2007;176(6):532-555.
6. Pellegrino R, Viegi G, Brusasco V, Crapo RO, Burgos F, Casaburi R, et al. Interpretative strategies for lung function tests. Eur Respir J 2005;26(5):948-968.
7. Meyer KC. Aging. Proc Am Thorac Soc 2005;2(5):433-439.
8. Stanojevic S, Wade A, Stocks J, Hankinson J, Coates AL, Pan H, et al. Reference ranges for spirometry across all ages. Am J Respir Crit Care Med 2008;177(3):253-260.
9. Stanojevic S, Wade A, Stocks J. Reference values for lung function: past, present and future. Eur Respir J 2010;36(1):12-19.
10. Hansen JF, Sun X-G, Wasserman K. Spirometric criteria for airway obstruction. Chest 2007;131(2):349-355.
11. Vaz Fragoso CA, Concato J, McAvay G, Van Ness PH, Rochester CL, Yaggi HK, Gill TM. Defining chronic obstructive pulmonary disease in older persons. Respir Med 2009;103(10):1468-1476.
12. Vaz Fragoso CA, Concato J, McAvay G, Van Ness PH, Rochester CL, Yaggi HK, Gill TM. Chronic obstructive pulmonary disease in older persons: a comparison of two spirometric definitions. Respir Med 2010;104(8):1189-1196.
13. Vaz Fragoso CA, Concato J, McAvay G, Van Ness PH, Rochester CL, Yaggi HK, Gill TM. The ratio of the forced expiratory volume in 1-second to forced vital capacity in establishing chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2010;181(5):446-451.
14. Quanjer PH, Enright PL, Ruppel GL. The GOLD guidelines definition of mild airway obstruction. Respir Care 2010;55(10):1397-1399.
15. Cummings SR, Bates D, Black DM. Clinical use of bone densitometry: scientific review. JAMA 2002;288(15):1889-1897.
16. US Department of Health and Human Services. National Center for Health Statistics. Third National Health and Nutrition Examination Survey, 1988-94, NHANES III Laboratory Data File (CD-ROM), Public Use Data File Documentation Number 76200. Hyattsville, Maryland: Centers for Disease Control and Prevention; 1996.
17. Williams OD on behalf of the ARIC investigators. The atherosclerosis risk in communities (ARIC) study: design and objectives. The Am J Epidemiol 1989;129(4):687-702.
18. Miller MR, Hankinson J, Brusasco V, Burgos F, Casaburi R, Coates A, et al. Standardisation of spirometry. Eur Respir J 2005;26(2):319-338.
19. Becklake M, Crapo RO on behalf of the American Thoracic Society. Lung function testing: selection of reference values and interpretative strategies. Am Rev Respir Dis 1991;144(5):1202-1218.
20. Mannino DM, Buist AS, Vollmer WM. Chronic obstructive pulmonary disease in the older adult: what defines abnormal lung function? Thorax 2007;62(3):237-241.
21. Hankinson JL, Odencrantz JR, Fedan KB. Spirometric reference values from a sample of the general US population. Am J Respir Crit Care Med 1999;159(1):179-87.
22. Wheatcroft G, Cox CS, Lochner KA. Comparative analysis of the NHANES III public-use and restricted-use linked mortality files. Hyattsville, Maryland: National Center for Health Statistics; 2007.
23. Peduzzi P, Concato J, Feinstein AR, Holford TR. Importance of events per independent variable in proportional hazards regression analysis. II. Accuracy and precision of regression estimates. J Clin Epidemiol 1995;48(12):1503-1510.
24. SUDAAN language manual, release 9.0 Research Triangle Institute; 2004.
25. SAS/STAT 9.2 user's guide. SAS Institute; 2008.
26. Gross NJ. Chronic obstructive pulmonary disease outcome measurements. Proc Am Thorac Soc 2005;2(4):267-271.
27. Cherry DK, Burt CW, Woodwell DA. National ambulatory medical care survey: 1999 summary. Advanced Data from Vital and Health Statistics 2001;322(July 17):1-36.
28. Qaseem A, Snow V, Shekelle P, Sherif K, Wilt TJ, Weinberger S, et al. Diagnosis and management of stable chronic obstructive pulmonary disease: a clinical practice guideline from the American college of physicians. Ann Intern Med 2007;147(9):633-638.
29. Celli BR, MacNee W for the American Thoracic Society and European Respiratory Society Task Force. Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper. Eur Respir J 2004;23(6):932-946.
30. Glady CA, Aaron SD, Lunau M, Clinch J, Dales R. Spirometrybased algorithm to direct lung function testing in the pulmonary function laboratory. Chest 2003;123(6):1939-1946.
31. Aaron SD, Dales RE, Cardinal PC. How accurate is spirometry at predicting restrictive pulmonary impairment? Chest 1999;(3):115:869-873.
32. Dransfield MT, Bailey WC. COPD: racial disparities in susceptibility, treatment, and outcomes. Clin Chest Med 2006;27(3):463-471.
33. Manolio TA, Weinmann GG, Buist SA, Furberg CD, Pinsky JL, Hurd SH. Pulmonary function testing in population-based studies. Am J Respir Crit Care Med 1997;156(3):1004-1010.